A Qualitative Study on Gratitude and Recognition Toward Living Kidney Donors (GRACE)

November 25, 2025 updated by: Assistance Publique - Hôpitaux de Paris

GRAtitude et Considération Envers Les Donneurs Vivants du Rein

Kidney transplantation is widely recognized as the best treatment for patients with end-stage renal disease. However, its development is limited by the persistent shortage of available organs. Living donor kidney transplantation offers the best functional and survival outcomes, yet the number of procedures remains insufficient.

Living kidney donation relies on a voluntary and altruistic act by a healthy individual who accepts surgery without direct medical benefit. This act of generosity raises important questions regarding how society acknowledges and values such commitment. The lack of formal recognition may contribute to the psychological burden experienced by some donors and may not adequately reflect the gratitude of the medical community and society toward them.

This study aims to explore the perceptions of living kidney donors regarding the potential implementation of a symbolic form of recognition (for instance, a commemorative medal) offered after donation. The hypothesis is that such recognition could improve donors' post-donation experience and strengthen the societal value associated with living organ donation, while fully respecting ethical principles prohibiting any financial reward.

This is a qualitative, monocentric study based on semi-structured interviews with individuals who have donated a kidney. The interviews will focus on donors' motivations, their personal experience of donation, and their opinions about different possible forms of post-donation recognition. Interviews will be recorded, transcribed verbatim, and analyzed using inductive thematic analysis to identify recurring themes and perspectives.

The main endpoint is the identification of thematic categories related to donors' perception of post-donation recognition and its potential impact on their experience. Secondary objectives include exploring donors' expectations regarding societal gratitude, their views on the symbolic value of such recognition, and the potential influence on future donor engagement.

The findings of this study are expected to contribute to the ethical reflection surrounding the acknowledgment of living donors, support initiatives promoting non-financial recognition, and help develop respectful and meaningful ways of expressing societal gratitude toward those who make the gift of life possible.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Individuals who have donated a kidney at Hôpital Saint-Louis between January 1, 2020, and December 31, 2025, or are currently engaged in a living kidney donation process with nephrectomy scheduled before June 30, 2026.
  • Age ≥ 18 years.
  • Able to provide informed consent.

Exclusion Criteria:

  • Refusal or opposition to participate in the study.
  • Individuals under legal protection (guardianship, curatorship, or legal safeguard).
  • Individuals deprived of liberty by judicial or administrative decision.
  • Individuals under 18 years of age.
  • Kidney donation performed in a hospital other than Hôpital Saint-Louis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Living donors of Kidney
This cohort includes individuals who have donated a kidney at Hôpital Saint-Louis between January 1, 2020, and December 31, 2025, as well as individuals currently engaged in a living kidney donation process with a nephrectomy planned before June 30, 2026, in the same institution. Participants will take part in semi-structured qualitative interviews exploring their perceptions and experiences related to post-donation recognition.

Participants will take part in a one-on-one semi-structured qualitative interview exploring their experiences and perceptions related to living kidney donation and potential forms of post-donation recognition.

The interview guide includes open-ended questions addressing:

  • Personal motivations for donation;
  • Emotional and relational experiences throughout the donation process;
  • Ethical perceptions of living donation;
  • Views on symbolic recognition (e.g., commemorative medal, public acknowledgment, ceremony);
  • Perceptions of paired kidney donation (KPD);
  • Social representations of living donation in their personal environment and in society.

Interviews will last approximately 45 to 60 minutes and will be conducted either in person at Hôpital Saint-Louis or via secure videoconference.

All interviews will be recorded, transcribed verbatim, anonymized, and analyzed using inductive thematic analysis (NVivo or equivalent software).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Themes related to donor perceptions of post-donation recognition
Time Frame: At baseline
Inductive thematic analysis of semi-structured interviews with living kidney donors, identifying key themes and subthemes related to their perception of post-donation recognition or symbolic rewards (e.g., commemorative medal, public acknowledgment).
At baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceptions of Kidney Paired Donation (KPD)
Time Frame: At baseline

Exploration of participants' views and emotional responses toward kidney paired donation programs, including ethical and logistical aspects.

A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

At baseline
Initial Motivations for Donation
Time Frame: At baseline

Identification of personal, relational, or altruistic motivations that led participants to consider or complete living kidney donation.

A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

At baseline
Experience of the Donation Pathway
Time Frame: At baseline

Evaluation of participants' experiences throughout the donation process, including emotional journey, perceived support, and acknowledgment by healthcare professionals.

A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

At baseline
Ethical Perceptions of Living Donation and Symbolic Recognition
Time Frame: At baseline

Analysis of ethical reflections expressed by donors regarding the concept of recognition, symbolic rewards, or institutional gratitude (e.g., medals, diplomas, ceremonies).

A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

At baseline
Social Representations of Living Donation
Time Frame: At baseline

Investigation of how donors perceive societal and familial views about living kidney donation, including stigma, admiration, or misunderstanding.

A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

At baseline
Barriers or Reluctance Toward Kidney Paired Donation
Time Frame: At baseline

Identification of logistical, emotional, or ethical barriers expressed by participants regarding paired exchange donation.

A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

November 18, 2025

First Submitted That Met QC Criteria

November 25, 2025

First Posted (Actual)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

November 28, 2025

Last Update Submitted That Met QC Criteria

November 25, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kidney Transplantation

Clinical Trials on Semi-structured qualitative interview

Subscribe